CoChat

Effects of L-theanine on cognition, mood and sleep: evidence from human trials

Open access
Cotter, Jack, Kilpatrick, Hannah E. · 2026 · Frontiers in Nutrition

The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index; 62 of the 111 sources its claims cite were checked for support.

Abstract

L-theanine is a naturally occurring, non-proteinogenic amino acid found in the tea plant Camellia sinensis and some mushrooms. The widespread consumption of tea, together with its long history of traditional use for supporting various aspects of wellbeing, has led to significant scientific interest in the effects of L-theanine. Much of this research has focused on L-theanine's ability to modulate the central nervous system and related functions. This has also led to its inclusion in dietary supplements for its purported effects on human health and performance. In this mini-review, we summarize the latest evidence on L-theanine and its effects on cognition, mood and sleep based on systematic reviews and meta-analyses of human randomized controlled trials. We also examine evidence relating to its safety, consider limitations of the existing scientific literature and highlight key areas for future research. Current evidence in healthy adults suggests that supplementation with 100–400mg of L-theanine can produce small but statistically significant improvements in aspects of cognitive performance, particularly on visual attention tasks and when combined with caffeine. It has also been reported to reduce both perceived and physiological markers of stress and anxiety under stress-inducing conditions at doses of 200–400mg/day, without causing sedation. Additionally, trials report that supplementation with 200–450mg/day of L-theanine can support sleep quality, with little effect on total sleep duration. Supplementation with L-theanine has generally been reported to be well-tolerated in clinical trials. Further high-quality studies are warranted to establish optimal dosing strategies, clarify underlying mechanisms and evaluate potential interactions with other bioactive compounds.

Overview

CoChat Summary

TL;DR

This mini-review synthesizes systematic reviews and meta-analyses of human randomized controlled trials on L-theanine, concluding that 100–400 mg supports aspects of cognition (especially visual attention and when combined with caffeine), 200–400 mg/day reduces perceived and physiological stress/anxiety without sedation, and 200–450 mg/day supports sleep quality without increasing total sleep duration. The authors characterize the evidence as promising but limited by small study numbers, small-to-moderate effect sizes, and unclear optimal dosing.

Key findings

  • Cognition: Mátyus et al. (5 RCTs, n = 148) found a dose-dependent benefit on rapid visual information processing and recognition visual reaction time [MD = −15.20 ms, 95% CI (−28.99, −1.41)], with non-significant effects on simple reaction time and Stroop congruent/incongruent stimuli. Payne et al. (6 RCTs, n = 147) found a small-to-moderate benefit on choice reaction time in the first hour [SMD = −0.35, 95% CI (−0.61, −0.10), p = 0.02] and dose-dependent effects on rapid visual information processing reaction time [SMD = −0.17, p = 0.04] and accuracy [SMD = 0.17, p = 0.02] in the second hour, with no significant effects on simple reaction time or digit vigilance.
  • Mood: Williams et al. (9 RCTs, n = 270) concluded 200–400 mg/day may reduce stress and anxiety in people exposed to stressful conditions, though evidence for chronic conditions was insufficient. Moshfeghinia et al. (11 RCTs, n = 563) found reduced psychiatric symptoms versus placebo in some trials in schizophrenia, anxiety disorders and ADHD, but urged caution; a network meta-analysis found L-theanine did not outperform placebo for anxiety disorder symptoms based on a single trial.
  • Sleep: Bulman et al. (19 RCTs, n = 897) reported significant improvements in subjective sleep onset latency [SMD = 0.15, p = 0.04], daytime dysfunction [SMD = 0.33, p < 0.001] and overall subjective sleep quality [SMD = 0.43, p = 0.03], with no significant differences for sleep duration. Cotter et al. (13 trials, n = 550) concluded 200–450 mg/day supports healthy sleep, most robustly for sleep quality markers.
  • Safety/dosing: L-theanine was generally well-tolerated with few and only mild adverse effects across included studies; effects appear within a ~100–400 mg window, with ≥200 mg seemingly needed for stress-relieving and sleep effects. A standard 200 mL cup of green or black tea contains only ~8–25 mg of L-theanine.

Methods

  • Design: narrative mini-review summarizing the latest evidence from systematic reviews and meta-analyses of human randomized controlled trials on L-theanine, cognition, mood and sleep, plus safety and future research directions.
  • Data: literature search using the keyword "theanine" in PubMed and Google Scholar, covering publications up to and including June 2026; the review centers on the most comprehensive (typically most recent) systematic reviews in each domain, summarized in Tables 1 and 2.
  • Analysis: narrative synthesis of pooled effect estimates (MD/SMD with confidence intervals) from the cited meta-analyses and conclusions from narrative reviews; no new primary data or independent meta-analysis was conducted.

Limitations

  • Stated: the small number of studies in the cognition meta-analyses warrants cautious interpretation; direct dose–response assessments within the 100–400 mg range are limited and inconsistent; evidence is insufficient to recommend L-theanine as a treatment for clinical symptoms or chronic stress/psychiatric conditions; efficacy in clinical insomnia is largely unevaluated; optimal dosing, timing and duration remain unclear; and the authors note they are unaware of any further standalone-intervention RCTs published since the Cotter et al. search.
  • Stated: small-to-moderate effect sizes mean large samples are needed to reliably detect differences, which may explain inconsistent findings in smaller studies.
  • Evident from the text: as a narrative mini-review with no stated formal protocol, quality appraisal or independent pooling, conclusions rest on the authors' selection of the "most comprehensive" reviews; the cognition reviews draw on largely overlapping studies, and the sleep meta-analysis pools standalone and combination interventions, which the authors acknowledge limits disentangling L-theanine's independent contribution.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fnut.2026.1922819

Cites

61 of 62 references verified0 citation errors · 1 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

34 Valid · 0 Not valid · 14 Not checked · 23 Own results and interpretations

33 more claims · 13 with their cited sources checked

Create a free account to see all 71 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 9
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. Song, 2003, Effects of theanine on the release of brain alpha wave in adult males, Korean J Nutr., 36, 918

Metadata

Authors
Cotter, J., & Kilpatrick, H. E.
Affiliations
Research and Development, The Water Street Collective Ltd
Corresponding author
Cotter, Jack
Venue
Frontiers in Nutrition
Published
2026-09-04
Volume
13
Pages
1922819-1922819
ISSN
2296-861X (ISSN-L)
OpenAlex
W7208757723
Cited by
0
References
61
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Nutrition (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
Keywords
theanine, tea, cognitive performance, visual attention, mood, anxiety, stress, sleep quality, dietary supplements, safety, dose-response relationship

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of L-theanine on cognition, mood and sleep: evidence from human trials. https://app.cochat.ai/papers/10.3389/fnut.2026.1922819
The paper
Cotter, J., & Kilpatrick, H. E. (2026). Effects of L-theanine on cognition, mood and sleep: evidence from human trials. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2026.1922819

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.